Arcus Biosciences, Inc. (RCUS)

Pharmaceutical Preparations

Latest Price

$24.32

TTM P/E

Normalized P/E

Div Yield

Book Value

3.69

P/B Ratio

6.59

Valuation metrics

Base FCF: $432M (median of recent 5yr)

Growth: 5%/yr (median YOY, capped at 25%)

Discount rate: 10%

Terminal growth: 3%

Projection horizon: 10 years

DCF Fair Value

$59.77

+146% upside

97.3% held by institutions

Institution	Shares	Value	Ownership %	Change	Filing Date
GILEAD SCIENCES, INC.	31.42M	$968.0M	24.74%	--	2026-06-30
BlackRock, Inc.	16.42M	$506.0M	12.93%	+1.19M	2026-06-30
STATE STREET CORP	6.03M	$185.0M	4.75%	+616.6K	2026-06-30
WELLINGTON MANAGEMENT GROUP LLP	5.90M	$181.0M	4.64%	-194.1K	2026-06-30
MONTANOVA CAPITAL, LLC	4.78M	$147.0M	3.76%	-254.6K	2026-06-30
VANGUARD PORTFOLIO MANAGEMENT LLC	4.48M	$137.0M	3.52%	+203.5K	2026-06-30
FMR LLC	4.05M	$124.0M	3.19%	+2.88M	2026-06-30
VANGUARD CAPITAL MANAGEMENT LLC	3.89M	$119.0M	3.06%	+31.6K	2026-06-30
CITADEL ADVISORS LLC	3.16M	$97.0M	2.49%	+1.74M	2026-06-30
Woodline Partners LP	3.01M	$92.0M	2.37%	-770.0K	2026-06-30